Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

NCT04430842 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104

NCT04349969 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

NCT06533332 ·Status: RECRUITING ·Phase: PHASE1

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

NCT04592484 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of DM005 in Patients With Advanced Solid Tumors

NCT06515990 ·Status: RECRUITING ·Phase: PHASE1

To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation

NCT04052971 ·Status: COMPLETED ·Phase: PHASE1

Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors

NCT05642949 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

NCT06431594 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114

NCT05200273 ·Status: UNKNOWN ·Phase: PHASE1

Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05474859 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies

NCT06224855 ·Status: RECRUITING ·Phase: PHASE1

Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors

NCT03510104 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors

NCT06707610 ·Status: RECRUITING ·Phase: PHASE1

A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors

NCT05716295 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

IMX-110 in Patients With Advanced Solid Tumors

NCT03382340 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors

NCT03352531 ·Status: COMPLETED ·Phase: PHASE1

MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors

NCT00591682 ·Status: SUSPENDED ·Phase: PHASE1

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

NCT05410145 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors

NCT00569036 ·Status: COMPLETED ·Phase: PHASE1

HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies

NCT06649708 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-2206-002)

NCT00670488 ·Status: COMPLETED ·Phase: PHASE1

A Study of PYX-201 in Advanced Solid Tumors

NCT05720117 ·Status: RECRUITING ·Phase: PHASE1

A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumors

NCT02410512 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT06307795 ·Status: RECRUITING ·Phase: PHASE1

MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors

NCT02517398 ·Status: COMPLETED ·Phase: PHASE1